131 related articles for article (PubMed ID: 34520731)
1. Beneficial effects of inorganic nitrate in non-alcoholic fatty liver disease.
Liu Y; Croft KD; Caparros-Martin J; O'Gara F; Mori TA; Ward NC
Arch Biochem Biophys; 2021 Oct; 711():109032. PubMed ID: 34520731
[TBL] [Abstract][Full Text] [Related]
2. Long-term dietary nitrate supplementation slows the progression of established atherosclerosis in ApoE
Liu Y; Croft KD; Mori TA; Gaspari TA; Kemp-Harper BK; Ward NC
Eur J Nutr; 2023 Jun; 62(4):1845-1857. PubMed ID: 36853380
[TBL] [Abstract][Full Text] [Related]
3. [Liraglutide protects against nonalcoholic fatty liver disease in ApoE knockout mice with high-fat diet and silenced Acrp30 by increasing AMPK].
Zhao XY; Zhang LL; Suolang QZ; Yang GY; Li L; Li SB; Chen WW
Zhonghua Gan Zang Bing Za Zhi; 2014 Nov; 22(11):849-53. PubMed ID: 25531383
[TBL] [Abstract][Full Text] [Related]
4. Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats.
Liu J; Han L; Zhu L; Yu Y
Lipids Health Dis; 2016 Feb; 15():27. PubMed ID: 26868515
[TBL] [Abstract][Full Text] [Related]
5. Cranberry Attenuates Progression of Non-alcoholic Fatty Liver Disease Induced by High-Fat Diet in Mice.
Shimizu K; Ono M; Imoto A; Nagayama H; Tetsumura N; Terada T; Tomita K; Nishinaka T
Biol Pharm Bull; 2019; 42(8):1295-1302. PubMed ID: 31366865
[TBL] [Abstract][Full Text] [Related]
6. Low dose dietary nitrate improves endothelial dysfunction and plaque stability in the ApoE
Bakker JR; Bondonno NP; Gaspari TA; Kemp-Harper BK; McCashney AJ; Hodgson JM; Croft KD; Ward NC
Free Radic Biol Med; 2016 Oct; 99():189-198. PubMed ID: 27519268
[TBL] [Abstract][Full Text] [Related]
7. Concurrent exercise improves insulin resistance and nonalcoholic fatty liver disease by upregulating PPAR-γ and genes involved in the beta-oxidation of fatty acids in ApoE-KO mice fed a high-fat diet.
Zheng F; Cai Y
Lipids Health Dis; 2019 Jan; 18(1):6. PubMed ID: 30611282
[TBL] [Abstract][Full Text] [Related]
8. LPSF/GQ-02 inhibits the development of hepatic steatosis and inflammation in a mouse model of non-alcoholic fatty liver disease (NAFLD).
Soares e Silva AK; de Oliveira Cipriano Torres D; dos Santos Gomes FO; dos Santos Silva B; Lima Ribeiro E; Costa Oliveira A; dos Santos LA; de Lima Mdo C; Pitta Ida R; Peixoto CA
PLoS One; 2015; 10(4):e0123787. PubMed ID: 25875942
[TBL] [Abstract][Full Text] [Related]
9. Effects of eicosapentaenoic acid on hepatic dyslipidemia and oxidative stress in high fat diet-induced steatosis.
Hirotani Y; Ozaki N; Tsuji Y; Urashima Y; Myotoku M
Int J Food Sci Nutr; 2015; 66(5):569-73. PubMed ID: 26017323
[TBL] [Abstract][Full Text] [Related]
10. Melatonin improves non-alcoholic fatty liver disease via MAPK-JNK/P38 signaling in high-fat-diet-induced obese mice.
Sun H; Wang X; Chen J; Song K; Gusdon AM; Li L; Bu L; Qu S
Lipids Health Dis; 2016 Nov; 15(1):202. PubMed ID: 27876064
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of bile acid composition in high fat diet-induced nonalcoholic fatty liver disease in obese diabetic rats.
Nakade Y; Kitano R; Sakamoto K; Kimoto S; Yamauchi T; Inoue T; Kobayashi Y; Ohashi T; Sumida Y; Ito K; Yoneda M
PLoS One; 2021; 16(2):e0247303. PubMed ID: 33626072
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous knockout of Bile salt export pump ameliorates liver steatosis in mice fed a high-fat diet.
Okushin K; Tsutsumi T; Ikeuchi K; Kado A; Enooku K; Fujinaga H; Yamauchi N; Ushiku T; Moriya K; Yotsuyanagi H; Koike K
PLoS One; 2020; 15(8):e0234750. PubMed ID: 32785220
[TBL] [Abstract][Full Text] [Related]
13. The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD).
Wang Z; Li S; Wang R; Guo L; Xu D; Zhang T; Xu Y; Wang W; Wang M; Gan Z; Wang X
Mol Med; 2020 Jun; 26(1):54. PubMed ID: 32503411
[TBL] [Abstract][Full Text] [Related]
14. Fish oil alleviates circadian bile composition dysregulation in male mice with NAFLD.
Liu Y; Li Q; Wang H; Zhao X; Li N; Zhang H; Chen G; Liu Z
J Nutr Biochem; 2019 Jul; 69():53-62. PubMed ID: 31055233
[TBL] [Abstract][Full Text] [Related]
15. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC
Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380
[TBL] [Abstract][Full Text] [Related]
16. Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE
Nasiri-Ansari N; Nikolopoulou C; Papoutsi K; Kyrou I; Mantzoros CS; Kyriakopoulos G; Chatzigeorgiou A; Kalotychou V; Randeva MS; Chatha K; Kontzoglou K; Kaltsas G; Papavassiliou AG; Randeva HS; Kassi E
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467546
[TBL] [Abstract][Full Text] [Related]
17. The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis.
Schumacher JD; Kong B; Pan Y; Zhan L; Sun R; Aa J; Rizzolo D; Richardson JR; Chen A; Goedken M; Aleksunes LM; Laskin DL; Guo GL
Toxicol Appl Pharmacol; 2017 Sep; 330():1-8. PubMed ID: 28673684
[TBL] [Abstract][Full Text] [Related]
18. [Effects of celastrol on autophagy and endoplasmic reticulum stress-mediated apoptosis in a mouse model of nonalcoholic fatty liver disease].
Tian T; Liao XC; Zhang M; Wu XM; Guo YT; Tan SY
Zhonghua Gan Zang Bing Za Zhi; 2022 Jun; 30(6):656-662. PubMed ID: 36038329
[No Abstract] [Full Text] [Related]
19. The polyherbal drug GGEx18 from Laminaria japonica, Rheum palmatum, and Ephedra sinica inhibits hepatic steatosis and fibroinflammtion in high-fat diet-induced obese mice.
Lim J; Lee H; Ahn J; Kim J; Jang J; Park Y; Jeong B; Yang H; Shin SS; Yoon M
J Ethnopharmacol; 2018 Oct; 225():31-41. PubMed ID: 29958960
[TBL] [Abstract][Full Text] [Related]
20. Rebalancing glucolipid metabolism and gut microbiome dysbiosis by nitrate-dependent alleviation of high-fat diet-induced obesity.
Ma L; Hu L; Jin L; Wang J; Li X; Wang W; Chang S; Zhang C; Wang J; Wang S
BMJ Open Diabetes Res Care; 2020 Aug; 8(1):. PubMed ID: 32843498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
